Ercros, S.A. (BME: ECR)

Market Cap	323.68M
Revenue (ttm)	656.52M
Net Income (ttm)	14.10M
Shares Out	91.44M
EPS (ttm)	n/a
PE Ratio	22.95
Forward PE	88.50
Dividend	0.10 (2.71%)
Ex-Dividend Date	Jul 8, 2024

Volume	93,967
Open	3.530
Previous Close	3.540
Day's Range	3.530 - 3.565
52-Week Range	2.260 - 3.980
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 21, 2025

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s prod...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,253
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2023, Ercros's revenue was 726.29 million, a decrease of -29.19% compared to the previous year's 1.03 billion. Earnings were 27.59 million, a decrease of -56.21%.